The MS pipeline is full of potential. Which therapies will be on the front line in tomorrow’s battle against MS?
By Zac Haughn, Senior Associate Editor
Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.
By Flavia Nelson, MD
A recent analysis has created a better profile of who can receive Tysabri and when.
By Q&A with Robert J. Fox, MD
Physicians who do not meet the federal EHR meaningful use standards by October 2014 will face Medicare payment cuts of one percent in 2015; two percent in 2016.
By Zubin Emsley
The right approaches to financial planning can help protect and grow a physician’s assets, even as troubling trends persist.
By Brian Luster and Steven Abernathy
Spinal Injury from Electrocautery Shock
By Theodore Conliffe, MD; Zach Broyer, MD; Jonas Matzon, MD; Lisa Marino, DO; Pedro Beredjiklian, MD; Jeremy Simon, MD; and Michael Mehnert, MD Section Editor: Steven Mandel, MD
Cognitive Complications of Elective Surgery and Anesthesia
By Ronald Devere, MD, FAAN
Botulinum Toxin for Urinary Incontinence